Market Research Logo

Proteomics International Laboratories Ltd (PIQ) - Product Pipeline Analysis, 2017 Update

Summary

Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of proteins. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and drug discovery. Proteomics International developed PromarkerD, a predictive test for the diagnosis of diabetic kidney disease. Its analytical services include pharmacokinetic testing, biosimilars or biologic drug characterization, and proteome mapping. The company works on the discovery of painkillers and antibiotics drug compounds from animal venom, as part of its drug discovery efforts. Proteomics International is headquartered in Nedlands, Western Australia, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Proteomics International Laboratories Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Proteomics International Laboratories Ltd Company Overview
Proteomics International Laboratories Ltd Company Snapshot
Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
Proteomics International Laboratories Ltd – Pipeline Analysis Overview
Proteomics International Laboratories Ltd - Key Facts
Proteomics International Laboratories Ltd - Major Products and Services
Proteomics International Laboratories Ltd Pipeline Products by Development Stage
Proteomics International Laboratories Ltd Pipeline Products Overview
Diagnostic Test - Alzheimer's Disease
Diagnostic Test - Alzheimer's Disease Product Overview
Diagnostic Test - Asbestos Related Conditions
Diagnostic Test - Asbestos Related Conditions Product Overview
Diagnostic Test - Endometriosis
Diagnostic Test - Endometriosis Product Overview
Diagnostic Test - Lung Conditions
Diagnostic Test - Lung Conditions Product Overview
Diagnostic Test - Parasitic Infections
Diagnostic Test - Parasitic Infections Product Overview
PromarkerD
PromarkerD Product Overview
PromarkerD (CDx)
PromarkerD (CDx) Product Overview
PromarkerD LDT
PromarkerD LDT Product Overview
Proteomics International Laboratories Ltd - Key Competitors
Proteomics International Laboratories Ltd - Key Employees
Proteomics International Laboratories Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Proteomics International Laboratories Ltd, Recent Developments
Dec 14, 2017: Dimerix and Proteomics partner to improve treatment of Chronic Kidney Disease
Nov 27, 2017: PromarkerD Predictive diagnostic test to launch in Q1 2018
Nov 22, 2017: Proteomics International strengthens Board and Business Development team
Aug 16, 2017: US PromarkerD Patent Expanded to All Kidney Disease
Jun 12, 2017: Clinical validation study confirms PromarkerD can predict diabetic kidney disease better than any current measure
May 09, 2017: Proteomics International becomes world’s most accredited protein testing laboratory, launches pharmacokinetic and companion diagnostic testing for clinical trials
Mar 21, 2017: World leading predictive diagnostic test for diabetic kidney disease crisis to roll-out in Asia with China and Singapore patents and commercialisation partners
Feb 08, 2017: PromarkerD diabetic kidney disease diagnostic test validated by EU peer-reviewed scientific journal
Dec 16, 2016: Diabetic Kidney Disease patent granted in Russia
Oct 27, 2015: US Patent granted for Predictive and Diagnostic Test for Diabetic Kidney Disease
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
Proteomics International Laboratories Ltd Pipeline Products by Indication
Proteomics International Laboratories Ltd, Key Facts
Proteomics International Laboratories Ltd, Major Products and Services
Proteomics International Laboratories Ltd Number of Pipeline Products by Development Stage
Proteomics International Laboratories Ltd Pipeline Products Summary by Development Stage
Diagnostic Test - Alzheimer's Disease - Product Status
Diagnostic Test - Alzheimer's Disease - Product Description
Diagnostic Test - Asbestos Related Conditions - Product Status
Diagnostic Test - Asbestos Related Conditions - Product Description
Diagnostic Test - Endometriosis - Product Status
Diagnostic Test - Endometriosis - Product Description
Diagnostic Test - Lung Conditions - Product Status
Diagnostic Test - Lung Conditions - Product Description
Diagnostic Test - Parasitic Infections - Product Status
Diagnostic Test - Parasitic Infections - Product Description
PromarkerD - Product Status
PromarkerD - Product Description
PromarkerD (CDx) - Product Status
PromarkerD (CDx) - Product Description
PromarkerD LDT - Product Status
PromarkerD LDT - Product Description
Proteomics International Laboratories Ltd, Key Employees
Proteomics International Laboratories Ltd, Other Locations
Glossary
List of Figures
Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
Proteomics International Laboratories Ltd Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report